

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.43240691 |
| 2 | vocalization behavior (GO:0071625) | 5.36495755 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.23448886 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.95215034 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.92367121 |
| 6 | protein-cofactor linkage (GO:0018065) | 4.88611509 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.79642382 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.69581135 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.53476261 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.47290010 |
| 11 | glutamate secretion (GO:0014047) | 4.44513118 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.42428602 |
| 13 | C4-dicarboxylate transport (GO:0015740) | 4.38725035 |
| 14 | nucleobase catabolic process (GO:0046113) | 4.33789958 |
| 15 | proline transport (GO:0015824) | 4.30911646 |
| 16 | protein localization to synapse (GO:0035418) | 4.30580747 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.24566680 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.19329941 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.11483641 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.10470777 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.05869082 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.05170477 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.04844508 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 3.98664081 |
| 25 | postsynaptic membrane organization (GO:0001941) | 3.97010175 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.93214516 |
| 27 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.89285488 |
| 28 | presynaptic membrane assembly (GO:0097105) | 3.89094705 |
| 29 | positive regulation of synapse maturation (GO:0090129) | 3.87963874 |
| 30 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.85855594 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 3.84293903 |
| 32 | synaptic vesicle maturation (GO:0016188) | 3.82407689 |
| 33 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.82323607 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.82004713 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75348546 |
| 36 | behavioral response to ethanol (GO:0048149) | 3.75005043 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.71015292 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.70832931 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.69494542 |
| 40 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.66988749 |
| 41 | behavioral response to nicotine (GO:0035095) | 3.65761045 |
| 42 | regulation of synaptic vesicle transport (GO:1902803) | 3.63516721 |
| 43 | cerebellar granule cell differentiation (GO:0021707) | 3.58874455 |
| 44 | positive regulation of protein homodimerization activity (GO:0090073) | 3.58311018 |
| 45 | exploration behavior (GO:0035640) | 3.57393209 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.46013512 |
| 47 | glycosphingolipid biosynthetic process (GO:0006688) | 3.44224296 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.43479515 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.43362457 |
| 50 | neurotransmitter transport (GO:0006836) | 3.43197810 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.42496767 |
| 52 | detection of calcium ion (GO:0005513) | 3.40832112 |
| 53 | DNA double-strand break processing (GO:0000729) | 3.39617289 |
| 54 | amino acid salvage (GO:0043102) | 3.38724575 |
| 55 | L-methionine salvage (GO:0071267) | 3.38724575 |
| 56 | L-methionine biosynthetic process (GO:0071265) | 3.38724575 |
| 57 | ubiquinone biosynthetic process (GO:0006744) | 3.37918374 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.36278647 |
| 59 | * positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.35415458 |
| 60 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.34751053 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.31394752 |
| 62 | regulation of sarcomere organization (GO:0060297) | 3.31339111 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.30959672 |
| 64 | neuron recognition (GO:0008038) | 3.25038317 |
| 65 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.23560293 |
| 66 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.23153138 |
| 67 | long-term memory (GO:0007616) | 3.21070408 |
| 68 | ubiquinone metabolic process (GO:0006743) | 3.20242812 |
| 69 | cellular potassium ion homeostasis (GO:0030007) | 3.19359304 |
| 70 | response to histamine (GO:0034776) | 3.17535709 |
| 71 | organelle disassembly (GO:1903008) | 3.17168331 |
| 72 | regulation of neurotransmitter levels (GO:0001505) | 3.16899014 |
| 73 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.15974141 |
| 74 | synapse assembly (GO:0007416) | 3.13614626 |
| 75 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12436994 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.12282526 |
| 77 | anterograde synaptic vesicle transport (GO:0048490) | 3.09081228 |
| 78 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.07709696 |
| 79 | regulation of postsynaptic membrane potential (GO:0060078) | 3.07648719 |
| 80 | phenol-containing compound catabolic process (GO:0019336) | 3.06460113 |
| 81 | regulation of cilium movement (GO:0003352) | 3.05916022 |
| 82 | regulation of neurotransmitter secretion (GO:0046928) | 3.05391103 |
| 83 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04834537 |
| 84 | succinate metabolic process (GO:0006105) | 3.04566284 |
| 85 | cell differentiation in hindbrain (GO:0021533) | 3.02797202 |
| 86 | positive regulation of mitochondrial fission (GO:0090141) | 3.01150288 |
| 87 | long-term synaptic potentiation (GO:0060291) | 3.00059415 |
| 88 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.99233859 |
| 89 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98593730 |
| 90 | axonal fasciculation (GO:0007413) | 2.97394902 |
| 91 | ribonucleoprotein complex disassembly (GO:0032988) | 2.96309444 |
| 92 | neuromuscular synaptic transmission (GO:0007274) | 2.94249860 |
| 93 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.94238671 |
| 94 | membrane hyperpolarization (GO:0060081) | 2.94203716 |
| 95 | metallo-sulfur cluster assembly (GO:0031163) | 2.93278635 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 2.93278635 |
| 97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.91589377 |
| 98 | synaptic transmission (GO:0007268) | 2.91449916 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 2.90354334 |
| 100 | piRNA metabolic process (GO:0034587) | 2.89586363 |
| 101 | neurotransmitter catabolic process (GO:0042135) | 2.88225980 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87882511 |
| 103 | synaptic vesicle endocytosis (GO:0048488) | 2.87424514 |
| 104 | fear response (GO:0042596) | 2.86163124 |
| 105 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.84817756 |
| 106 | protein neddylation (GO:0045116) | 2.84677745 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.84150209 |
| 108 | membrane depolarization (GO:0051899) | 2.83979219 |
| 109 | startle response (GO:0001964) | 2.82477878 |
| 110 | glycine transport (GO:0015816) | 2.82391255 |
| 111 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.80636045 |
| 112 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.80636045 |
| 113 | quinone biosynthetic process (GO:1901663) | 2.79074861 |
| 114 | hippocampus development (GO:0021766) | 2.78981838 |
| 115 | sequestering of actin monomers (GO:0042989) | 2.77630374 |
| 116 | positive regulation of synapse assembly (GO:0051965) | 2.77390297 |
| 117 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.77123744 |
| 118 | negative regulation of hormone metabolic process (GO:0032351) | 2.77123744 |
| 119 | neuromuscular process controlling posture (GO:0050884) | 2.74794916 |
| 120 | sulfation (GO:0051923) | 2.74461970 |
| 121 | regulation of synaptic plasticity (GO:0048167) | 2.72382494 |
| 122 | social behavior (GO:0035176) | 2.72368528 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.72368528 |
| 124 | establishment of mitochondrion localization (GO:0051654) | 2.71385006 |
| 125 | establishment of synaptic vesicle localization (GO:0097480) | 2.71101324 |
| 126 | synaptic vesicle transport (GO:0048489) | 2.71101324 |
| 127 | * positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.71048706 |
| 128 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.69991745 |
| 129 | positive regulation of neurotransmitter transport (GO:0051590) | 2.68498522 |
| 130 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.68310516 |
| 131 | photoreceptor cell maintenance (GO:0045494) | 2.67995872 |
| 132 | retinal cone cell development (GO:0046549) | 2.67930523 |
| 133 | neurotransmitter biosynthetic process (GO:0042136) | 2.67146990 |
| 134 | synapse organization (GO:0050808) | 2.66720412 |
| 135 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.66689873 |
| 136 | nonmotile primary cilium assembly (GO:0035058) | 2.66667937 |
| 137 | righting reflex (GO:0060013) | 2.66586955 |
| 138 | indole-containing compound catabolic process (GO:0042436) | 2.64123471 |
| 139 | indolalkylamine catabolic process (GO:0046218) | 2.64123471 |
| 140 | tryptophan catabolic process (GO:0006569) | 2.64123471 |
| 141 | fucose catabolic process (GO:0019317) | 2.63365676 |
| 142 | L-fucose metabolic process (GO:0042354) | 2.63365676 |
| 143 | L-fucose catabolic process (GO:0042355) | 2.63365676 |
| 144 | neurotransmitter metabolic process (GO:0042133) | 2.62848360 |
| 145 | protein polyglutamylation (GO:0018095) | 2.61250277 |
| 146 | axoneme assembly (GO:0035082) | 2.60877270 |
| 147 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.60739951 |
| 148 | dopamine transport (GO:0015872) | 2.58162039 |
| 149 | cellular response to leptin stimulus (GO:0044320) | 2.56702451 |
| 150 | dicarboxylic acid catabolic process (GO:0043649) | 2.56615882 |
| 151 | activated T cell proliferation (GO:0050798) | 2.55679031 |
| 152 | acidic amino acid transport (GO:0015800) | 2.54987955 |
| 153 | regulation of microtubule-based movement (GO:0060632) | 2.54671077 |
| 154 | indolalkylamine metabolic process (GO:0006586) | 2.54459469 |
| 155 | methionine biosynthetic process (GO:0009086) | 2.54207446 |
| 156 | inositol phosphate catabolic process (GO:0071545) | 2.52585513 |
| 157 | rRNA catabolic process (GO:0016075) | 2.51181057 |
| 158 | negative regulation of appetite (GO:0032099) | 2.49802105 |
| 159 | negative regulation of response to food (GO:0032096) | 2.49802105 |
| 160 | protein K11-linked deubiquitination (GO:0035871) | 2.48192436 |
| 161 | cellular biogenic amine catabolic process (GO:0042402) | 2.46677248 |
| 162 | amine catabolic process (GO:0009310) | 2.46677248 |
| 163 | anterograde axon cargo transport (GO:0008089) | 2.46554569 |
| 164 | regulation of collateral sprouting (GO:0048670) | 2.46203528 |
| 165 | tryptophan metabolic process (GO:0006568) | 2.45818374 |
| 166 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.45255772 |
| 167 | benzene-containing compound metabolic process (GO:0042537) | 2.43951748 |
| 168 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.43717550 |
| 169 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.42092464 |
| 170 | short-term memory (GO:0007614) | 2.41672471 |
| 171 | platelet dense granule organization (GO:0060155) | 2.41583179 |
| 172 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.38098012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.61690500 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01862060 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88869091 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86578491 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77669295 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.59775960 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.47128589 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41940092 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41940092 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41775189 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37163259 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34936372 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33818565 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.25188593 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24571438 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23050205 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18156876 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.14623195 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14499215 |
| 20 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06219775 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05176469 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94818728 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93493297 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92145406 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.91754878 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.91063473 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.89541494 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88158823 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87859624 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.81637578 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.81122073 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79253761 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78325220 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78271488 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77214514 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76401802 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76332992 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76311757 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.72322070 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67884099 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.67595597 |
| 42 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67081364 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.65830751 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.65830751 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63143313 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60571905 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.58995320 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.58754779 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56820659 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54789140 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54382152 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52663004 |
| 53 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52405672 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52393978 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.49392059 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48138101 |
| 57 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46954343 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44327285 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41020412 |
| 60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40378778 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.38995234 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37889540 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37866532 |
| 64 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.36756691 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36490484 |
| 66 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.34690834 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.34178292 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33030299 |
| 69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31713862 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31535948 |
| 71 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31245959 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30649520 |
| 73 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30117884 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.29078849 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27457703 |
| 76 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.27292156 |
| 77 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.27135592 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26002848 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25710182 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25427392 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25316423 |
| 82 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24359826 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23822228 |
| 84 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.23712423 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23113624 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23113624 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22721491 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21481152 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.21085241 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18859346 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18424904 |
| 92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17676875 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17622283 |
| 94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17309098 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16569693 |
| 96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15160926 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14986894 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14956988 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14793499 |
| 100 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14628534 |
| 101 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14628534 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13387492 |
| 103 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13315611 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13173751 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12869986 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11739873 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11219409 |
| 108 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10789730 |
| 109 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10614976 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09552422 |
| 111 | * JUN_21703547_ChIP-Seq_K562_Human | 1.08257015 |
| 112 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08246952 |
| 113 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08200922 |
| 114 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07645220 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07573416 |
| 116 | EWS_26573619_Chip-Seq_HEK293_Human | 1.05813579 |
| 117 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05800755 |
| 118 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05380007 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04817404 |
| 120 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03815723 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03134052 |
| 122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02380491 |
| 123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01867248 |
| 124 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01668629 |
| 125 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01388522 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99166355 |
| 127 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98849862 |
| 128 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98401221 |
| 129 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97934119 |
| 130 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97610854 |
| 131 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97588158 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97585048 |
| 133 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94159408 |
| 134 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93900970 |
| 135 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93793867 |
| 136 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93397940 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92981471 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91852044 |
| 139 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90636683 |
| 140 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90485923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.44638918 |
| 2 | MP0002822_catalepsy | 3.74510887 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.59227330 |
| 4 | MP0004270_analgesia | 3.39791226 |
| 5 | MP0003880_abnormal_central_pattern | 3.37534309 |
| 6 | MP0009046_muscle_twitch | 3.21532327 |
| 7 | MP0009745_abnormal_behavioral_response | 3.12965830 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 2.74938491 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.72081835 |
| 10 | MP0002064_seizures | 2.69934862 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.60839862 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.57563170 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.54083395 |
| 14 | MP0002272_abnormal_nervous_system | 2.42207398 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.33618875 |
| 16 | MP0001486_abnormal_startle_reflex | 2.33073070 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.26538235 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.21079361 |
| 19 | MP0005386_behavior/neurological_phenoty | 2.08820346 |
| 20 | MP0004924_abnormal_behavior | 2.08820346 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.04728571 |
| 22 | MP0002638_abnormal_pupillary_reflex | 2.01185544 |
| 23 | MP0002736_abnormal_nociception_after | 2.00489775 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.95492447 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.94832259 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.91388512 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.86910860 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.86577916 |
| 29 | MP0001970_abnormal_pain_threshold | 1.86171320 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.86018705 |
| 31 | MP0003787_abnormal_imprinting | 1.82631789 |
| 32 | MP0001905_abnormal_dopamine_level | 1.80662788 |
| 33 | MP0008569_lethality_at_weaning | 1.79736160 |
| 34 | MP0004215_abnormal_myocardial_fiber | 1.78509161 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.77066120 |
| 36 | MP0003646_muscle_fatigue | 1.72799794 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.70050511 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.68631829 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.66589379 |
| 40 | MP0002184_abnormal_innervation | 1.65830332 |
| 41 | MP0003879_abnormal_hair_cell | 1.63526018 |
| 42 | MP0004147_increased_porphyrin_level | 1.62324336 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.57370658 |
| 44 | MP0000778_abnormal_nervous_system | 1.51294154 |
| 45 | MP0001529_abnormal_vocalization | 1.50832432 |
| 46 | MP0001188_hyperpigmentation | 1.48797535 |
| 47 | MP0001984_abnormal_olfaction | 1.44149198 |
| 48 | MP0003121_genomic_imprinting | 1.42900719 |
| 49 | MP0004484_altered_response_of | 1.42601747 |
| 50 | MP0004043_abnormal_pH_regulation | 1.41186321 |
| 51 | MP0005253_abnormal_eye_physiology | 1.40464597 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.36835588 |
| 53 | MP0000751_myopathy | 1.32918439 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.32818461 |
| 55 | MP0003195_calcinosis | 1.31054903 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.30332931 |
| 57 | MP0003136_yellow_coat_color | 1.28002376 |
| 58 | MP0003011_delayed_dark_adaptation | 1.27140584 |
| 59 | MP0008872_abnormal_physiological_respon | 1.26930126 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.26722402 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.25217031 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.22971671 |
| 63 | MP0005394_taste/olfaction_phenotype | 1.19809488 |
| 64 | MP0005499_abnormal_olfactory_system | 1.19809488 |
| 65 | MP0002102_abnormal_ear_morphology | 1.19049156 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.14145464 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.14071594 |
| 68 | MP0001270_distended_abdomen | 1.11198744 |
| 69 | MP0003329_amyloid_beta_deposits | 1.10338126 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.09606925 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.09185805 |
| 72 | MP0004885_abnormal_endolymph | 1.09108995 |
| 73 | MP0003633_abnormal_nervous_system | 1.08435422 |
| 74 | MP0004142_abnormal_muscle_tone | 1.08072064 |
| 75 | MP0008058_abnormal_DNA_repair | 1.07964187 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 1.07846992 |
| 77 | MP0002332_abnormal_exercise_endurance | 1.07526471 |
| 78 | MP0005171_absent_coat_pigmentation | 1.07181640 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 1.05428858 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 1.04874386 |
| 81 | MP0000955_abnormal_spinal_cord | 1.03956314 |
| 82 | MP0004085_abnormal_heartbeat | 1.02179870 |
| 83 | MP0004858_abnormal_nervous_system | 1.01329770 |
| 84 | MP0004130_abnormal_muscle_cell | 1.00333567 |
| 85 | MP0003122_maternal_imprinting | 0.99269144 |
| 86 | MP0003631_nervous_system_phenotype | 0.98988301 |
| 87 | MP0001664_abnormal_digestion | 0.98411424 |
| 88 | MP0004233_abnormal_muscle_weight | 0.96820110 |
| 89 | MP0004742_abnormal_vestibular_system | 0.94244626 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.91895782 |
| 91 | MP0005535_abnormal_body_temperature | 0.91360353 |
| 92 | MP0010329_abnormal_lipoprotein_level | 0.91229412 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.91144467 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.90892870 |
| 95 | MP0002152_abnormal_brain_morphology | 0.90385122 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.90163373 |
| 97 | MP0001764_abnormal_homeostasis | 0.90037853 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.89665016 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.88710750 |
| 100 | MP0000049_abnormal_middle_ear | 0.86809442 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 0.84851573 |
| 102 | MP0005187_abnormal_penis_morphology | 0.84178532 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.83673957 |
| 104 | MP0003698_abnormal_male_reproductive | 0.82887696 |
| 105 | MP0001929_abnormal_gametogenesis | 0.80484196 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.79439244 |
| 107 | MP0005620_abnormal_muscle_contractility | 0.79392241 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.78971313 |
| 109 | MP0002752_abnormal_somatic_nervous | 0.78622844 |
| 110 | MP0009379_abnormal_foot_pigmentation | 0.77311973 |
| 111 | MP0006138_congestive_heart_failure | 0.77118466 |
| 112 | MP0002229_neurodegeneration | 0.76389483 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.75015365 |
| 114 | MP0002163_abnormal_gland_morphology | 0.74974149 |
| 115 | MP0005365_abnormal_bile_salt | 0.74052600 |
| 116 | MP0003724_increased_susceptibility_to | 0.73681235 |
| 117 | MP0002090_abnormal_vision | 0.73469212 |
| 118 | MP0002233_abnormal_nose_morphology | 0.71231567 |
| 119 | MP0001177_atelectasis | 0.71119426 |
| 120 | MP0000465_gastrointestinal_hemorrhage | 0.69917009 |
| 121 | MP0004133_heterotaxia | 0.69803066 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.69468922 |
| 123 | MP0003632_abnormal_nervous_system | 0.69324262 |
| 124 | MP0008874_decreased_physiological_sensi | 0.68281449 |
| 125 | MP0004036_abnormal_muscle_relaxation | 0.65814830 |
| 126 | MP0006292_abnormal_olfactory_placode | 0.65260960 |
| 127 | MP0008877_abnormal_DNA_methylation | 0.64747935 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 0.64716801 |
| 129 | MP0000516_abnormal_urinary_system | 0.64716801 |
| 130 | MP0000569_abnormal_digit_pigmentation | 0.64392519 |
| 131 | MP0000026_abnormal_inner_ear | 0.62816521 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.60599198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.78654190 |
| 2 | Focal seizures (HP:0007359) | 5.21734653 |
| 3 | Atonic seizures (HP:0010819) | 5.15990329 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.87637093 |
| 5 | Febrile seizures (HP:0002373) | 4.86706978 |
| 6 | Visual hallucinations (HP:0002367) | 4.79430265 |
| 7 | Hypothermia (HP:0002045) | 4.56592106 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.56066386 |
| 9 | Myokymia (HP:0002411) | 4.23816677 |
| 10 | Hyperventilation (HP:0002883) | 3.97462844 |
| 11 | Absence seizures (HP:0002121) | 3.94113566 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.66536624 |
| 13 | Dialeptic seizures (HP:0011146) | 3.59564053 |
| 14 | Action tremor (HP:0002345) | 3.56089192 |
| 15 | Progressive inability to walk (HP:0002505) | 3.49790867 |
| 16 | Abnormality of the labia minora (HP:0012880) | 3.45876883 |
| 17 | Broad-based gait (HP:0002136) | 3.42402692 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.34222598 |
| 19 | Limb dystonia (HP:0002451) | 3.23725683 |
| 20 | Amblyopia (HP:0000646) | 3.10698352 |
| 21 | Genetic anticipation (HP:0003743) | 3.10208517 |
| 22 | Split foot (HP:0001839) | 3.01727409 |
| 23 | Inability to walk (HP:0002540) | 2.93632459 |
| 24 | Poor eye contact (HP:0000817) | 2.92412460 |
| 25 | Pancreatic cysts (HP:0001737) | 2.90290814 |
| 26 | Dysdiadochokinesis (HP:0002075) | 2.89030304 |
| 27 | Hyperglycinemia (HP:0002154) | 2.87060347 |
| 28 | Pheochromocytoma (HP:0002666) | 2.85416441 |
| 29 | Gait imbalance (HP:0002141) | 2.84691017 |
| 30 | Lissencephaly (HP:0001339) | 2.69871336 |
| 31 | Ankle clonus (HP:0011448) | 2.68041250 |
| 32 | Diplopia (HP:0000651) | 2.64978765 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.64978765 |
| 34 | Type II lissencephaly (HP:0007260) | 2.63759528 |
| 35 | Absent speech (HP:0001344) | 2.61454653 |
| 36 | Anxiety (HP:0000739) | 2.60765819 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 2.60505715 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60505715 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.58346195 |
| 40 | Abnormal social behavior (HP:0012433) | 2.58241642 |
| 41 | Impaired social interactions (HP:0000735) | 2.58241642 |
| 42 | Pachygyria (HP:0001302) | 2.57892064 |
| 43 | Hemiparesis (HP:0001269) | 2.54916037 |
| 44 | Dysmetric saccades (HP:0000641) | 2.53937798 |
| 45 | Hyperglycinuria (HP:0003108) | 2.51560007 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.50738464 |
| 47 | Decreased central vision (HP:0007663) | 2.49305322 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.48227966 |
| 49 | Polyphagia (HP:0002591) | 2.47742072 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.44725737 |
| 51 | Excessive salivation (HP:0003781) | 2.42583830 |
| 52 | Drooling (HP:0002307) | 2.42583830 |
| 53 | Congenital primary aphakia (HP:0007707) | 2.39732526 |
| 54 | True hermaphroditism (HP:0010459) | 2.39146973 |
| 55 | Renal cortical cysts (HP:0000803) | 2.34619644 |
| 56 | Lipid accumulation in hepatocytes (HP:0006561) | 2.34470771 |
| 57 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33144110 |
| 58 | Acute encephalopathy (HP:0006846) | 2.33067887 |
| 59 | Amyotrophic lateral sclerosis (HP:0007354) | 2.32515788 |
| 60 | Failure to thrive in infancy (HP:0001531) | 2.29302259 |
| 61 | Retinal dysplasia (HP:0007973) | 2.26711262 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.24451805 |
| 63 | Hyperthyroidism (HP:0000836) | 2.24164951 |
| 64 | Pancreatic fibrosis (HP:0100732) | 2.23769638 |
| 65 | Abnormality of midbrain morphology (HP:0002418) | 2.22120358 |
| 66 | Molar tooth sign on MRI (HP:0002419) | 2.22120358 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.21241068 |
| 68 | Depression (HP:0000716) | 2.20545200 |
| 69 | Dysmetria (HP:0001310) | 2.20406867 |
| 70 | Abnormality of the renal cortex (HP:0011035) | 2.16627523 |
| 71 | Scanning speech (HP:0002168) | 2.15772437 |
| 72 | Colon cancer (HP:0003003) | 2.14177713 |
| 73 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14100707 |
| 74 | Progressive macrocephaly (HP:0004481) | 2.13589993 |
| 75 | Oligomenorrhea (HP:0000876) | 2.13144545 |
| 76 | Medial flaring of the eyebrow (HP:0010747) | 2.12779171 |
| 77 | Horizontal nystagmus (HP:0000666) | 2.12389694 |
| 78 | Spastic tetraplegia (HP:0002510) | 2.11917741 |
| 79 | Truncal ataxia (HP:0002078) | 2.11181826 |
| 80 | Impaired smooth pursuit (HP:0007772) | 2.09989224 |
| 81 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09971025 |
| 82 | Abnormal hair whorl (HP:0010721) | 2.09669177 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 2.09602603 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07431166 |
| 85 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06527348 |
| 86 | Urinary urgency (HP:0000012) | 2.05474387 |
| 87 | Pendular nystagmus (HP:0012043) | 2.04017037 |
| 88 | Syncope (HP:0001279) | 2.03646920 |
| 89 | Fair hair (HP:0002286) | 2.03541077 |
| 90 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03391525 |
| 91 | Increased CSF lactate (HP:0002490) | 2.03083395 |
| 92 | Blue irides (HP:0000635) | 2.03035471 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02346392 |
| 94 | Abnormality of alanine metabolism (HP:0010916) | 2.02346392 |
| 95 | Hyperalaninemia (HP:0003348) | 2.02346392 |
| 96 | Specific learning disability (HP:0001328) | 2.00959454 |
| 97 | Acute necrotizing encephalopathy (HP:0006965) | 2.00804173 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98783744 |
| 99 | Protruding tongue (HP:0010808) | 1.98753490 |
| 100 | Cerebral edema (HP:0002181) | 1.96989048 |
| 101 | Hemiplegia (HP:0002301) | 1.95881280 |
| 102 | Narrow nasal bridge (HP:0000446) | 1.94973151 |
| 103 | Increased hepatocellular lipid droplets (HP:0006565) | 1.94430079 |
| 104 | Nonprogressive disorder (HP:0003680) | 1.94071389 |
| 105 | Myotonia (HP:0002486) | 1.94069491 |
| 106 | Mitochondrial inheritance (HP:0001427) | 1.93732885 |
| 107 | Exotropia (HP:0000577) | 1.91569789 |
| 108 | Rimmed vacuoles (HP:0003805) | 1.90593101 |
| 109 | Hypsarrhythmia (HP:0002521) | 1.89879160 |
| 110 | Genital tract atresia (HP:0001827) | 1.89743840 |
| 111 | Prolonged QT interval (HP:0001657) | 1.89594021 |
| 112 | Hepatocellular necrosis (HP:0001404) | 1.89322005 |
| 113 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.88768714 |
| 114 | Exercise-induced myalgia (HP:0003738) | 1.86397449 |
| 115 | Neonatal hypoglycemia (HP:0001998) | 1.85436010 |
| 116 | Methylmalonic acidemia (HP:0002912) | 1.85412976 |
| 117 | Stereotypic behavior (HP:0000733) | 1.85371092 |
| 118 | Status epilepticus (HP:0002133) | 1.85228320 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.85219049 |
| 120 | Muscular hypotonia of the trunk (HP:0008936) | 1.83982236 |
| 121 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83936605 |
| 122 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.83881313 |
| 123 | Absent/shortened dynein arms (HP:0200106) | 1.83881313 |
| 124 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.83860333 |
| 125 | Agitation (HP:0000713) | 1.83838446 |
| 126 | Poor coordination (HP:0002370) | 1.83276379 |
| 127 | Cerebral hypomyelination (HP:0006808) | 1.80067508 |
| 128 | Vaginal atresia (HP:0000148) | 1.79653499 |
| 129 | Poor suck (HP:0002033) | 1.79174306 |
| 130 | Abnormal protein glycosylation (HP:0012346) | 1.78099152 |
| 131 | Abnormal glycosylation (HP:0012345) | 1.78099152 |
| 132 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78099152 |
| 133 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78099152 |
| 134 | Volvulus (HP:0002580) | 1.77871106 |
| 135 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.77455930 |
| 136 | Mutism (HP:0002300) | 1.77393808 |
| 137 | Stomach cancer (HP:0012126) | 1.77089513 |
| 138 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76815187 |
| 139 | Abnormality of the corticospinal tract (HP:0002492) | 1.75562392 |
| 140 | Nephronophthisis (HP:0000090) | 1.75297130 |
| 141 | Abnormal EKG (HP:0003115) | 1.74651368 |
| 142 | Bile duct proliferation (HP:0001408) | 1.74579979 |
| 143 | Abnormal biliary tract physiology (HP:0012439) | 1.74579979 |
| 144 | Esotropia (HP:0000565) | 1.74541212 |
| 145 | Spastic gait (HP:0002064) | 1.74539847 |
| 146 | Optic disc pallor (HP:0000543) | 1.74037535 |
| 147 | Impaired vibratory sensation (HP:0002495) | 1.72889192 |
| 148 | Lethargy (HP:0001254) | 1.72658018 |
| 149 | Postural tremor (HP:0002174) | 1.72636674 |
| 150 | Atrial fibrillation (HP:0005110) | 1.72627218 |
| 151 | Primary atrial arrhythmia (HP:0001692) | 1.72543570 |
| 152 | Inappropriate behavior (HP:0000719) | 1.72151053 |
| 153 | Left ventricular hypertrophy (HP:0001712) | 1.70671814 |
| 154 | Papillary thyroid carcinoma (HP:0002895) | 1.67924541 |
| 155 | Gait ataxia (HP:0002066) | 1.67217343 |
| 156 | Bradykinesia (HP:0002067) | 1.67160392 |
| 157 | Enlarged penis (HP:0000040) | 1.66958984 |
| 158 | Bradycardia (HP:0001662) | 1.66901793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.77508083 |
| 2 | MAP3K12 | 3.37212103 |
| 3 | MAP3K4 | 3.35142987 |
| 4 | NTRK3 | 3.34111749 |
| 5 | MAP2K7 | 3.27848833 |
| 6 | MAP4K2 | 3.09433487 |
| 7 | WNK3 | 3.05381564 |
| 8 | MARK1 | 2.68819345 |
| 9 | MUSK | 2.63488721 |
| 10 | MAP3K9 | 2.59300015 |
| 11 | EPHA4 | 2.26315251 |
| 12 | TRIM28 | 2.25610677 |
| 13 | BCR | 2.13298012 |
| 14 | MAP2K4 | 2.07780562 |
| 15 | TAOK3 | 2.07012201 |
| 16 | LMTK2 | 2.06983353 |
| 17 | MAPK13 | 1.91082882 |
| 18 | TNIK | 1.89568639 |
| 19 | MAP3K6 | 1.87123349 |
| 20 | STK38L | 1.86608763 |
| 21 | NUAK1 | 1.84429983 |
| 22 | CAMKK2 | 1.78053344 |
| 23 | GRK5 | 1.72574228 |
| 24 | KSR2 | 1.69970386 |
| 25 | DAPK2 | 1.68771099 |
| 26 | NTRK2 | 1.59151109 |
| 27 | MINK1 | 1.57820446 |
| 28 | NTRK1 | 1.53962498 |
| 29 | CDK19 | 1.53344019 |
| 30 | ARAF | 1.53010359 |
| 31 | RIPK4 | 1.50811420 |
| 32 | CSNK1G1 | 1.49348828 |
| 33 | OBSCN | 1.44564213 |
| 34 | VRK1 | 1.41911444 |
| 35 | ERBB3 | 1.39994848 |
| 36 | PLK2 | 1.37870185 |
| 37 | PAK6 | 1.32239788 |
| 38 | LATS2 | 1.32095898 |
| 39 | ERBB4 | 1.31944008 |
| 40 | ZAK | 1.28683191 |
| 41 | FRK | 1.26643972 |
| 42 | CSNK1A1L | 1.24598416 |
| 43 | SGK2 | 1.24142829 |
| 44 | PHKG1 | 1.24010388 |
| 45 | PHKG2 | 1.24010388 |
| 46 | GRK7 | 1.19351999 |
| 47 | TIE1 | 1.17766335 |
| 48 | GRK1 | 1.13649165 |
| 49 | BCKDK | 1.13245264 |
| 50 | DAPK1 | 1.12776295 |
| 51 | PIK3CA | 1.08665567 |
| 52 | CAMKK1 | 1.08501045 |
| 53 | CAMK2A | 1.05015340 |
| 54 | PDK4 | 1.03913290 |
| 55 | PDK3 | 1.03913290 |
| 56 | CAMK1G | 1.03474128 |
| 57 | CDK5 | 1.01331271 |
| 58 | KSR1 | 1.00833500 |
| 59 | CDK8 | 0.99180658 |
| 60 | BMPR1B | 0.97753873 |
| 61 | CCNB1 | 0.97689976 |
| 62 | EPHA3 | 0.97115270 |
| 63 | MKNK2 | 0.96220446 |
| 64 | PRKCE | 0.95449258 |
| 65 | BMPR2 | 0.94549113 |
| 66 | PNCK | 0.93566274 |
| 67 | SGK494 | 0.92605706 |
| 68 | SGK223 | 0.92605706 |
| 69 | MAP3K13 | 0.92364143 |
| 70 | CAMK1 | 0.91780860 |
| 71 | TXK | 0.90912858 |
| 72 | RAF1 | 0.90187347 |
| 73 | MAPKAPK5 | 0.89030309 |
| 74 | PRKCG | 0.88331171 |
| 75 | MYLK | 0.85166100 |
| 76 | RPS6KA4 | 0.84406704 |
| 77 | CSNK1G2 | 0.84320461 |
| 78 | UHMK1 | 0.79939564 |
| 79 | MAPK7 | 0.76449422 |
| 80 | GRK6 | 0.76375472 |
| 81 | OXSR1 | 0.75864169 |
| 82 | AKT3 | 0.74959070 |
| 83 | INSRR | 0.74748187 |
| 84 | MAP2K1 | 0.74352481 |
| 85 | CAMK1D | 0.73861715 |
| 86 | BRAF | 0.70852010 |
| 87 | PRPF4B | 0.70754497 |
| 88 | FGFR2 | 0.69634662 |
| 89 | PLK3 | 0.68227547 |
| 90 | SRPK1 | 0.67576952 |
| 91 | RET | 0.67154125 |
| 92 | SGK3 | 0.67052574 |
| 93 | STK11 | 0.66604719 |
| 94 | CAMK2B | 0.66286223 |
| 95 | ADRBK2 | 0.65448801 |
| 96 | ACVR1B | 0.63381016 |
| 97 | STK38 | 0.61948110 |
| 98 | PRKCZ | 0.59172077 |
| 99 | DYRK1A | 0.58800535 |
| 100 | SIK2 | 0.57960209 |
| 101 | SGK1 | 0.57807859 |
| 102 | ADRBK1 | 0.57402928 |
| 103 | MAP3K5 | 0.56165829 |
| 104 | DYRK3 | 0.56111310 |
| 105 | CAMK2D | 0.55284878 |
| 106 | FGR | 0.55238315 |
| 107 | MAPK12 | 0.54637912 |
| 108 | SYK | 0.54617676 |
| 109 | FES | 0.53823600 |
| 110 | MAP3K2 | 0.53353304 |
| 111 | CDK3 | 0.53282092 |
| 112 | PTK2B | 0.52685787 |
| 113 | CSNK1D | 0.51838539 |
| 114 | CDK18 | 0.51691014 |
| 115 | RPS6KA5 | 0.51450457 |
| 116 | CDK15 | 0.51301641 |
| 117 | TEC | 0.50263882 |
| 118 | PKN1 | 0.50144257 |
| 119 | PRKD3 | 0.50129016 |
| 120 | PRKAA2 | 0.49221829 |
| 121 | PINK1 | 0.48698848 |
| 122 | CAMK2G | 0.47630577 |
| 123 | MARK2 | 0.46723957 |
| 124 | CSF1R | 0.46554240 |
| 125 | CDK14 | 0.45077707 |
| 126 | DYRK2 | 0.44070483 |
| 127 | CAMK4 | 0.43976407 |
| 128 | CDK11A | 0.43102709 |
| 129 | NEK6 | 0.42483534 |
| 130 | PRKACA | 0.40904856 |
| 131 | RIPK1 | 0.40635584 |
| 132 | CSNK1G3 | 0.39432031 |
| 133 | IGF1R | 0.39000865 |
| 134 | PRKCQ | 0.38337593 |
| 135 | LIMK1 | 0.38209916 |
| 136 | PDK2 | 0.37423735 |
| 137 | PRKG1 | 0.36997799 |
| 138 | MATK | 0.36719807 |
| 139 | TYRO3 | 0.36586120 |
| 140 | CSNK1A1 | 0.36284883 |
| 141 | PAK3 | 0.35481163 |
| 142 | PRKACG | 0.35090802 |
| 143 | PRKCA | 0.32713768 |
| 144 | PRKACB | 0.30903043 |
| 145 | STK16 | 0.29267655 |
| 146 | CSNK1E | 0.28706187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77106011 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97137433 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87161338 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.76589025 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62733260 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60884900 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50293455 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.44846774 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31239065 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25579922 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.23147022 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19760795 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 2.11814458 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.07639651 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.05617236 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05415288 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.95003216 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.89630743 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.83754625 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.83449162 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77758649 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73217305 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.72643199 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71987145 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68213345 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.67460325 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.62393889 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.59287050 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58531115 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57266036 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56581618 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55909716 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54138920 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.50374795 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47481883 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.42955465 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.42302370 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41743803 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41436129 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40479550 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38717729 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.33323476 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.30838937 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30752178 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28058533 |
| 46 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26079610 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23851948 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23218691 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21519686 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21283577 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20373723 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.18778254 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.18191754 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18010905 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17285926 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.14925742 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13801653 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11770223 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11597158 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.11583002 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09759962 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09129965 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07876814 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04620172 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03835457 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03723366 |
| 67 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.02922459 |
| 68 | Protein export_Homo sapiens_hsa03060 | 1.01599366 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01355455 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00565268 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99610630 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99505478 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99031957 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98750133 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98375815 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94673279 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94061659 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93913396 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93290467 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.93068181 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92903859 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92686358 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90995419 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.88445945 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88170409 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.87721041 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87608438 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86170698 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85507111 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84983636 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84254598 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83222905 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.80890833 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79096174 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76690072 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75671073 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75188297 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74586347 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72051362 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70491285 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69648059 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.68035260 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67618230 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64600723 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64020893 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62513454 |
| 107 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62186222 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.61806274 |
| 109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61389649 |
| 110 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58351756 |
| 111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57711249 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55839495 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53970029 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53227822 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52233225 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51919130 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51764750 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49798264 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.49705239 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48836625 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48084242 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47983733 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45994129 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45212990 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44777693 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43504308 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42971730 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42766505 |
| 129 | Alcoholism_Homo sapiens_hsa05034 | 0.42276087 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41391614 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.41345371 |
| 132 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40503309 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39253679 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39090622 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.38659888 |
| 136 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37267663 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37153415 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.37089374 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.36150191 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.35286263 |
| 141 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34690016 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33043229 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32607555 |
| 144 | Proteasome_Homo sapiens_hsa03050 | 0.31193074 |
| 145 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31002805 |
| 146 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30585861 |
| 147 | Platelet activation_Homo sapiens_hsa04611 | 0.29499959 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28084368 |
| 149 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27316670 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26970458 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25046392 |
| 152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.22735724 |

